Daan W.A. van den Nieuwenhof MD , Esther J.P.C. van Bergen MD , Corrie E. Erasmus MD, PhD , Corinne P.A. Delsing MD, PhD , Karen van Hulst MD, PhD , Stijn Bekkers MD, PhD , Frank J.A. van den Hoogen MD, PhD
{"title":"神经发育障碍患者手术流口水治疗的长期疗效:一项回顾性队列研究。","authors":"Daan W.A. van den Nieuwenhof MD , Esther J.P.C. van Bergen MD , Corrie E. Erasmus MD, PhD , Corinne P.A. Delsing MD, PhD , Karen van Hulst MD, PhD , Stijn Bekkers MD, PhD , Frank J.A. van den Hoogen MD, PhD","doi":"10.1016/j.jpeds.2025.114807","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To compare the long-term treatment outcomes of submandibular duct relocation (SMDR), submandibular gland excision (SMGE), and submandibular duct ligation (SDL) for the treatment of anterior drooling in individuals with neurodevelopmental disabilities.</div></div><div><h3>Study design</h3><div>A retrospective cohort study was conducted with patients from the Netherlands who received surgery for drooling. All participants received follow-up after 8 and 32 weeks. A questionnaire was completed at least 1 year postsurgery for long-term follow-up. Visual analog scale (VAS) for drooling was the primary outcome. Secondary outcomes included the Drooling Quotient and the Drooling Severity and Frequency Scale. Repeated measures ANOVA was employed to assess the outcomes within and between each type of surgery.</div></div><div><h3>Results</h3><div>A total of 255 patients who visited the Saliva Control Clinic between 2000 and 2021 were included in this study. For the VAS at long-term follow-up, a mean reduction was observed of 44.9 points for SMDR (<em>P</em> < .001), 27.2 for SMGE (<em>P</em> < .001), and 25.4 for SDL (<em>P</em> < .001). VAS increased by within-surgery difference at long-term compared with 32 weeks for SMGE (8.6, <em>P</em> = .036) and SDL (8.5, <em>P</em> = .047), but not for SMDR (2.9, <em>P</em> = .46). When comparing the three types of surgery, the outcomes after SMDR remained stable in the long term, while the VAS increased for SMGE (mean difference 18.9, <em>P</em> = .011) and SDL (mean difference 18.5, <em>P</em> = .013).</div></div><div><h3>Conclusions</h3><div>VAS for drooling, Drooling Quotient, and Drooling Severity Frequency Scale decreased after all surgical procedures. SMDR showed superior outcomes over SMGE and SDL in the long term. Our data suggest partial recurrence of drooling after SDL and SMGE.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"288 ","pages":"Article 114807"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-Term Outcomes of Surgical Drooling Treatment in Individuals with Neurodevelopmental Disabilities: A Retrospective Cohort Study\",\"authors\":\"Daan W.A. van den Nieuwenhof MD , Esther J.P.C. van Bergen MD , Corrie E. Erasmus MD, PhD , Corinne P.A. Delsing MD, PhD , Karen van Hulst MD, PhD , Stijn Bekkers MD, PhD , Frank J.A. van den Hoogen MD, PhD\",\"doi\":\"10.1016/j.jpeds.2025.114807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To compare the long-term treatment outcomes of submandibular duct relocation (SMDR), submandibular gland excision (SMGE), and submandibular duct ligation (SDL) for the treatment of anterior drooling in individuals with neurodevelopmental disabilities.</div></div><div><h3>Study design</h3><div>A retrospective cohort study was conducted with patients from the Netherlands who received surgery for drooling. All participants received follow-up after 8 and 32 weeks. A questionnaire was completed at least 1 year postsurgery for long-term follow-up. Visual analog scale (VAS) for drooling was the primary outcome. Secondary outcomes included the Drooling Quotient and the Drooling Severity and Frequency Scale. Repeated measures ANOVA was employed to assess the outcomes within and between each type of surgery.</div></div><div><h3>Results</h3><div>A total of 255 patients who visited the Saliva Control Clinic between 2000 and 2021 were included in this study. For the VAS at long-term follow-up, a mean reduction was observed of 44.9 points for SMDR (<em>P</em> < .001), 27.2 for SMGE (<em>P</em> < .001), and 25.4 for SDL (<em>P</em> < .001). VAS increased by within-surgery difference at long-term compared with 32 weeks for SMGE (8.6, <em>P</em> = .036) and SDL (8.5, <em>P</em> = .047), but not for SMDR (2.9, <em>P</em> = .46). When comparing the three types of surgery, the outcomes after SMDR remained stable in the long term, while the VAS increased for SMGE (mean difference 18.9, <em>P</em> = .011) and SDL (mean difference 18.5, <em>P</em> = .013).</div></div><div><h3>Conclusions</h3><div>VAS for drooling, Drooling Quotient, and Drooling Severity Frequency Scale decreased after all surgical procedures. SMDR showed superior outcomes over SMGE and SDL in the long term. Our data suggest partial recurrence of drooling after SDL and SMGE.</div></div>\",\"PeriodicalId\":54774,\"journal\":{\"name\":\"Journal of Pediatrics\",\"volume\":\"288 \",\"pages\":\"Article 114807\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatrics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022347625003488\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022347625003488","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
Long-Term Outcomes of Surgical Drooling Treatment in Individuals with Neurodevelopmental Disabilities: A Retrospective Cohort Study
Objective
To compare the long-term treatment outcomes of submandibular duct relocation (SMDR), submandibular gland excision (SMGE), and submandibular duct ligation (SDL) for the treatment of anterior drooling in individuals with neurodevelopmental disabilities.
Study design
A retrospective cohort study was conducted with patients from the Netherlands who received surgery for drooling. All participants received follow-up after 8 and 32 weeks. A questionnaire was completed at least 1 year postsurgery for long-term follow-up. Visual analog scale (VAS) for drooling was the primary outcome. Secondary outcomes included the Drooling Quotient and the Drooling Severity and Frequency Scale. Repeated measures ANOVA was employed to assess the outcomes within and between each type of surgery.
Results
A total of 255 patients who visited the Saliva Control Clinic between 2000 and 2021 were included in this study. For the VAS at long-term follow-up, a mean reduction was observed of 44.9 points for SMDR (P < .001), 27.2 for SMGE (P < .001), and 25.4 for SDL (P < .001). VAS increased by within-surgery difference at long-term compared with 32 weeks for SMGE (8.6, P = .036) and SDL (8.5, P = .047), but not for SMDR (2.9, P = .46). When comparing the three types of surgery, the outcomes after SMDR remained stable in the long term, while the VAS increased for SMGE (mean difference 18.9, P = .011) and SDL (mean difference 18.5, P = .013).
Conclusions
VAS for drooling, Drooling Quotient, and Drooling Severity Frequency Scale decreased after all surgical procedures. SMDR showed superior outcomes over SMGE and SDL in the long term. Our data suggest partial recurrence of drooling after SDL and SMGE.
期刊介绍:
The Journal of Pediatrics is an international peer-reviewed journal that advances pediatric research and serves as a practical guide for pediatricians who manage health and diagnose and treat disorders in infants, children, and adolescents. The Journal publishes original work based on standards of excellence and expert review. The Journal seeks to publish high quality original articles that are immediately applicable to practice (basic science, translational research, evidence-based medicine), brief clinical and laboratory case reports, medical progress, expert commentary, grand rounds, insightful editorials, “classic” physical examinations, and novel insights into clinical and academic pediatric medicine related to every aspect of child health. Published monthly since 1932, The Journal of Pediatrics continues to promote the latest developments in pediatric medicine, child health, policy, and advocacy.
Topics covered in The Journal of Pediatrics include, but are not limited to:
General Pediatrics
Pediatric Subspecialties
Adolescent Medicine
Allergy and Immunology
Cardiology
Critical Care Medicine
Developmental-Behavioral Medicine
Endocrinology
Gastroenterology
Hematology-Oncology
Infectious Diseases
Neonatal-Perinatal Medicine
Nephrology
Neurology
Emergency Medicine
Pulmonology
Rheumatology
Genetics
Ethics
Health Service Research
Pediatric Hospitalist Medicine.